James Woodruff Lillie serves as Executive at MapLight Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James Woodruff Lillie has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 31,395 shares valued at $0.
James Woodruff Lillie currently holds 31,395 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Woodruff Lillie has been a net neutral trader of MPLT stock. They have purchased $0 and sold $0 worth of shares.
James Woodruff Lillie's most recent insider trade was on Feb 5, 2026, when they sold 31,395 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2025 | MPLT | $0 | Award | 32,539 | $N/A | Discretionary |